Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00998452 · ClinicalTrials.gov registry record · NA
Dissemination of a Weight Management Program Among US Veterans
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 732
- Enrollment target
NCT00998452: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT00998452 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 732 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (48% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00998452, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 732 participants
- Enrollment target
Study Summary
This study is being conducted with the Veterans Affairs National Center for Health Promotion and Disease Prevention (VANCP), which is overseeing the current dissemination of MOVE! (Managing Overweight/Obesity for Veterans Everywhere), a national weight management program for veterans. It will be based at 10 local sites in the national network of VA medical settings and community-based outpatient clinics and will compare two different models for disseminating and implementing MOVE! using a randomized experimental design. One study arm will implement the MOVE\* VETS! (Volunteer Education and Tailored Self-management and support) model that includes tailored newsletters and peer counseling MI calls and activities, and the other will receive the standard MOVE! program.
Interventions
- BEHAVIORAL MOVE*VETS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 732 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-08 |
| Phase | NA |
What the finished NCT00998452 record still lists
NCT00998452 is an interventional study that assigns participants to a tested intervention. The registered 732 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (48% lower).
The record links to 0 conditions, and to 1 intervention - of which MOVE*VETS is the first listed.
NCT00998452 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00998452 about?
NCT00998452 is a clinical study titled "Dissemination of a Weight Management Program Among US Veterans". This study is being conducted with the Veterans Affairs National Center for Health Promotion and Disease Prevention (VANCP), which is overseeing the current dissemination of MOVE! (Managing Overweight/Obesity for Veterans Everywhere), a national weight management program for veterans. It will be bas...
What is the current status of trial NCT00998452?
This trial is currently completed. It is a NA study. The enrollment target is 732 participants. The study started on 2009-12. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00998452?
The interventions under investigation include: MOVE*VETS (BEHAVIORAL).
Who is sponsoring clinical trial NCT00998452?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00998452's enrollment target sits among peer trials
732 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06216301 · 734 participants · Phase 3
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
- NCT07231419 · 734 participants · Phase 3
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
- NCT03232918 · 730 participants · Phase 4
Oxytocin and Fetal Heart Rate Changes
- NCT05548283 · 730 participants · Phase 4
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia